Patients induced with IL-2 RA whose CNI maintenance therapy was cyclosporine A also showed significantly lower TTV loads 180 and 360 days after transplantation compared to patients induced with ATG and receiving tacrolimus as immunosuppressive maintenance therapy (P=0.004 and P=0.04, respectively). The gene discussed is IL2; the disease is rheumatoid arthritis.